Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity
Open Access
- 26 August 2013
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 110 (37) , 14912-14917
Abstract
Significance: Ether lipid levels are higher in tumors, but their specific function in cancer has remained unclear. We show here that the metabolic enzyme alkylglyceronephosphate synthase (AGPS), a critical step in the synthesis of ether lipids, is up-regulated across multiple types of aggressive human cancer cells and primary tumors. Inactivation of AGPS leads to significant impairments in cancer pathogenicity through not only lowering the levels of cellular ether lipids, but also by altering fatty acid, eicosanoid, and glycerophospholipid metabolism, resulting in an overall reduction in the levels of several oncogenic signaling lipids.Keywords
This publication has 29 references indexed in Scilit:
- An accelerated workflow for untargeted metabolomics using the METLIN databaseNature Biotechnology, 2012
- RAS oncogenes: weaving a tumorigenic webNature Reviews Cancer, 2011
- Monoacylglycerol Lipase Exerts Dual Control over Endocannabinoid and Fatty Acid Pathways to Support Prostate CancerChemistry & Biology, 2011
- The Glycerophospho Metabolome and Its Influence on Amino Acid Homeostasis Revealed by Brain Metabolomics of GDE1(−/−) MiceChemistry & Biology, 2010
- Posttranslational Regulation of Fatty Acyl-CoA Reductase 1, Far1, Controls Ether Glycerophospholipid SynthesisJournal of Biological Chemistry, 2010
- Eicosanoids and cancerNature Reviews Cancer, 2010
- Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer PathogenesisCell, 2010
- PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantificationNucleic Acids Research, 2009
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003